01. TechnologyProTransMilestones AchievedStudy TeamFirst indication: Type-1 DiabetesCellaviva
02. About NextCellBusiness ConceptHistory
MarketOrganisationCompany Structure
03. InvestorsShare IssueFinancial CalendarFinancial ReportsCorporate GovernanceThe ShareArchive
04. NewsPress ReleasesNewsCompany PresentationsCompany Analyses
05. ContactContact InformationSubscribe
English
/
Svenska
05.

Contact

Want to know more? Contact us by mail or phone and subscribe to our news and press releases.

Karolinska Institutet Science Park

Hälsovägen 7, 141 57 Huddinge, Sweden
Map

Mathias Svahn, CEO
Sofia Fredrikson, CFO

Phone: +46 (0)8 735 55 95
Email: info@nextcellpharma.com

Subscribe

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please try again.